|Day's Range||49.4800 - 50.0100|
|52 Week Range||41.3800 - 51.7400|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.40%|
GlaxoSmithKline’s (GSK) HIV business is managed by ViiV Healthcare, a global specialist company in HIV medicines.
On April 27, 2017, Novartis was trading at a forward PE multiple of ~15.8x. The industry currently trades at a forward PE multiple of ~15.9x.
On April 25, 2017, Novartis (NVS) reported a 2.0% rise in revenues at constant currencies for 1Q17. Revenues fell due to a 3.0% negative impact of foreign exchange.